Research Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Research Review
Research Review Faculty of Science and Engineering University of Groningen 2017 Quality Assurance Netherlands Universities (QANU) Catharijnesingel 56 PO Box 8035 3503 RA Utrecht The Netherlands Phone: +31 (0) 30 230 3100 E-mail: [email protected] Internet: www.qanu.nl Project number: 0651 © 2017 QANU Text and numerical material from this publication may be reproduced in print, by photocopying or by any other means with the permission of QANU if the source is mentioned. 2 Research review Faculty of Science and Engineering, University of Groningen CONTENTS 1. INTRODUCTION COMMITTEE CHAIR ............................................................................. 5 2. THE REVIEW COMMITTEE AND THE PROCEDURES ........................................................ 7 3. GENERAL REMARKS AT FACULTY LEVEL ...................................................................... 11 4. GRADUATE SCHOOL OF SCIENCE AND ENGINEERING ................................................. 19 5. REVIEW OF THE VAN SWINDEREN INSTITUTE FOR PARTICLE PHYSICS AND GRAVITY (VSI) .............................................................................................................................. 23 6. REVIEW OF THE ENGINEERING AND TECHNOLOGY INSTITUTE GRONINGEN (ENTEG) 27 7. REVIEW OF THE ZERNIKE INSTITUTE FOR ADVANCED MATERIALS (ZIAM) ................ 31 8. REVIEW OF THE STRATINGH INSTITUTE FOR CHEMISTRY ......................................... 35 9. REVIEW OF THE GRONINGEN BIOMOLECULAR SCIENCES AND BIOTECHNOLOGY INSTITUTE (GBB) .......................................................................................................... -
33V449 Afscheidscollege Danhof-Special.Indd
Prof.dr. Meindert Danhof Bespiegelingen over Farmacologie Reflections on Pharmacology Bij ons leer je de wereld kennen Bespiegelingen over Farmacologie Reflections on Pharmacology Meindert Danhof Leiden Academic Centre for Drugs Research Leiden University P.O. Box 9502 2300 RA Leiden The Netherlands Translation and editorial support: Corine Visser ISBN: 978-90-9030260-7 Copyright © Meindert Danhof, 2017 No part of this publication may be reproduced or transmitted in any form or by any means without written permission of the author. Content Bespiegelingen over Farmacologie 5 Reflections on Pharmacology 31 Appendices 53 Appendix A: Reflections on Pharmacology 55 “Four Decades of Research on Pharmacokinetics & Pharmacodynamics” Leiden, 31 March 2017 Appendix B: Overview of PhD theses of the division of Pharmacology 59 Bespiegelingen over Farmacologie Rede uitgesproken door prof.dr. Meindert Danhof ter gelegenheid van zijn afscheid als hoogleraar in de Farmacologie aan de Universiteit Leiden op vrijdag 31 maart 2017 Prof. dr. Meindert Danhof Proloog In mijn afscheidsrede beschrijf ik de ontwikkelingen in het siologie waar, in experimenten in levende proefdieren, de be- geneesmiddelonderzoek in de bijna 41 jaar dat ik bij de vak- ginselen van de fysiologie werden uitgelegd. Het was een eerste groep Farmacologie en het LACDR werkzaam was. Deze pro- kennismaking met farmacologie. Daarbij dienen we ons te loog heeft betrekking op de periode die daaraan voorafging, en realiseren dat kennis van de fysiologie voor een belangrijk deel waarin mijn belangstelling werd gewekt voor de farmacologie. is verkregen door de bestudering van de effecten van farmaca. Terugkijkend moet ik bekennen dat ik niet heb durven dromen Mijn studentassistentschap bracht mij in contact met Anton dat een loopbaan in het wetenschappelijk onderzoek mij ten Steffens, van oorsprong apotheker, werkzaam als onderzoeker deel zou vallen. -
3-8 October 2012 Amsterdam, the Netherlands WELCOME to the FIP
Congress Programme The FIP Centennial The future of pharmacy, Improving health be part of the creation! through responsible medicines use 3-8 october 2012 AMSTERDAM, THE NETHERLANDS WELCOME TO THE FIP. CENTENNIAL CONGRESS. IN AMSTERDAM!. Network and connect with pharmacists and pharmaceutical scientists from all over the world under the theme of ‘Improving health through responsible medicines use’. The chance to meet colleagues from every corner of the globe is here and yours, at the FIP World Congress of Pharmacy and Pharmaceutical Sciences, the leading interna tional event offering diverse learning opportunities for those active within all areas of pharmacy. In 2012, FIP is celebrating its 100 year anniversary and as such The main theme of the Centennial is Improving Health through hosting this FIP Centennial Congress, taking place from 3-8 October Responsible Medicines Use, a theme that calls on pharmacists in Amsterdam, The Netherlands – the home country of FIP since and pharmaceutical scientists to take their place as leaders in the its beginning. This Congress is not only a unique opportunity for healthcare team and do their part to usher in a new era of health- FIP to make a significant step in the fulfilment of our Vision and care on a global scale. The theme is supported by a world-class Mission, as adopted by FIP Council in 2008, but will be a turning programme of expert speakers, symposia, workshops and posters point for the profession on a global level – all present will set the that bring together participants from diverse areas of pharmacy stage for the future on a foundation of 100 years of progress. -
The Fip Centennial Congress in Amsterdam!
The FIP Centennial Improving health through responsible medicines use The future of pharmacy, be part of the creation! OCTOBER AMSTERDAM, THE NETHERLANDS www.fip.org/amsterdam2012 program_coverA4_def.indd 3 30-01-12 17:43 TIMELINE FIRST REGISTRATION DEADLINE JUNE SECOND REGISTRATION DEADLINE SEPTEMBER STAKEHOLDER ROUNDTABLES OCTOBER (BY INVITATION ONLY) MINISTERS SUMMIT OCTOBER (BY INVITATION ONLY) CONGRESS OPENS OCTOBER OPENING CEREMONY FOLLOWED BY OPENING EXHIBITION AND SHOWCASE OCTOBER WELCOME RECEPTION OCTOBER AMSTERDAM MUSEUM EVENING OCTOBER SECTION DINNERS OCTOBER CLOSING DINNER EVENT OCTOBER world congress of pharmacy and pharmaceutical sciences 2012 program_imagesA4_def.indd 4 30-01-12 12:37 TIMELINE Welcome to the FIP Centennial Congress in Amsterdam! FIRST REGISTRATION DEADLINE Network and connect with pharmacists and pharmaceutical The main theme of the Centennial is Improving Health Through JUNE scientists from all over the world under the theme of Responsible Medicines Use, a theme that calls on pharmacists ‘Improving Health Through Responsible Medicines Use’. and pharmaceutical scientists to take their place as leaders in SECOND REGISTRATION DEADLINE the healthcare team and do their part to usher in a new era of SEPTEMBER The chance to meet colleagues from every corner of the globe healthcare on a global scale. The theme will be supported by a is yours at the FIP World Congress of Pharmacy and world-class programme of expert speakers, symposia, Pharmaceutical Sciences. The FIP Congress is the leading workshops and posters that will bring together participants STAKEHOLDER ROUNDTABLES international event offering diverse learning opportunities for from diverse areas of pharmacy practice and pharmaceutical OCTOBER (BY INVITATION ONLY) those active within all areas of pharmacy. -
TI Pharma Report
TI PHARMA NEW TRACKS TO MEDICINES KNOW-HOW PRIORITY MEDICINES HUMAN CAPITAL NETWORKS LEGACY FOR THE FUTURE TI Pharma New tracks to medicines 1. Executive summary 3 2. Background 6 3. Know-how 14 4. Priority medicines 28 5. Human capital 40 6. Networks 48 7. Finance & operations 58 8. Legacy for the future 64 9. Appendix A: FES Review Committee report 76 10. Appendix B: FES portfolio projects and partners 94 CHAPTER 1. EXECUTIVE SUMMARY Building health and wealth based on scientific excellence New tracks to medicines Public-private partnerships within pharmaceutical Know-how research are now so successful that it is easy to Improved health and wealth, rooted in scientific forget how unlikely they once seemed. Less than excellence, were central FES portfolio objectives. a decade ago, partnership between academic organisations, major industry players and SMEs was Direct patient benefits have already resulted, rare, and when they did occur, they were usually including a safe morphine regimen for newborns; within isolated silos of activity. new clinical protocols for COPD; a vaccine candidate against acute myeloid leukaemia; a disease registry The FES-funded (Dutch natural gas reserve fund) for rare metabolic diseases (which will facilitate research portfolio triggered the creation of the Top development for these so-called orphan diseases); Institute Pharma (TI Pharma). Following an invitation and numerous other examples. from large and small industry players and leading academic organisations, the Dutch government New test methods have been developed, and highly stepped in to encourage partnerships that could promising molecules and compound libraries have improve pharmaceutical research. This followed up been identified.